Biblio

Export 226 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is D  [Clear All Filters]
2016
H. Jin Kim, Cha, J., Lee, J. - M., Shin, J. Soo, Jung, N. - Y., Kim, Y. Jin, Choe, Y. Seong, Lee, K. Han, Kim, S. Tae, Kim, J. Seung, Lee, J. Hong, Na, D. L., and Seo, S. Won, “Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.”, J Alzheimers Dis, vol. 50, no. 3, pp. 709-18, 2016.
S. Tu, Leyton, C. E., Hodges, J. R., Piguet, O., and Hornberger, M., “Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 49, no. 3, pp. 853-61, 2016.
E. Gómez-Tortosa, Prieto-Jurczynska, C., Serrano, S., Franco-Macías, E., Olivié, L., Gallego, J., Guerrero-López, R., Trujillo-Tiebas, M. José, Ayuso, C., Ruiz, P. García, Pérez-Pérez, J., and Sainz, M. José, “Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion.”, J Alzheimers Dis, vol. 52, no. 1, pp. 25-31, 2016.
L. Zeng, Liang, W., Pan, J., Cao, Y., Liu, J., Wang, Q., Wang, L., Zou, Y., Wang, K., Kong, L., Xie, H., Xu, W., Li, W., Zhao, W., Mi, S., Chen, Y., Cheng, S., Li, X., Cao, Q., Zeng, X., and Wang, N., “Do Chinese Researchers Conduct Ethical Research and Use Ethics Committee Review in Clinical Trials of Anti-Dementia Drugs? An Analysis of Biomedical Publications Originating from China.”, J Alzheimers Dis, vol. 52, no. 3, pp. 813-23, 2016.
K. A. Southam, Vincent, A. J., and Small, D. H., “Do Microglia Default on Network Maintenance in Alzheimer's Disease?”, J Alzheimers Dis, vol. 51, no. 3, pp. 657-69, 2016.
G. D. Femminella, Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J., and Edison, P., “Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?”, J Alzheimers Dis, vol. 51, no. 4, pp. 1275-89, 2016.
R. Taipa, Sousa, A. Luísa, Pires, M. Melo, and Sousa, N., “Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.”, J Alzheimers Dis, vol. 53, no. 2, pp. 403-17, 2016.
T. Schütt, Helboe, L., Pedersen, L. Østergaar, Waldemar, G., Berendt, M., and Pedersen, J. Torleif, “Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.”, J Alzheimers Dis, vol. 52, no. 2, pp. 433-49, 2016.
H. Jin, Chen, T., Li, G., Wang, C., Zhang, B., Cao, X., Sha, S., Wan, Q., and Chen, L., “Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ 1-42.”, J Alzheimers Dis, vol. 50, no. 2, pp. 501-16, 2016.
L. Trojano and Gainotti, G., “Drawing Disorders in Alzheimer's Disease and Other Forms of Dementia.”, J Alzheimers Dis, vol. 53, no. 1, pp. 31-52, 2016.
J. de Pedro-Cuesta, Martínez-Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. José Garc, Almazán-Isla, J., Ruiz-Tovar, M., Medrano, M. - J., Avellanal, F., Calero, O., and Calero, M., “Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
S. Gourmaud, Mouton-Liger, F., Abadie, C., Meurs, E. F., Paquet, C., and Hugon, J., “Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1659-1670, 2016.
Y. Pan, Liu, R., Terpstra, E., Wang, Y., Qiao, F., Wang, J., Tong, Y., and Pan, B., “Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 1-12, 2016.
M. Ułamek-Kozioł, Kocki, J., Bogucka-Kocka, A., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Furmaga-Jabłońska, W., Brzozowska, J., Czuczwar, S. J., and Pluta, R., “Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 113-21, 2016.
B. C. Beckelman, Day, S., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., C Keene, D., and Ma, T., “Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 669-78, 2016.
2015
D. N. Kiosses, Rosenberg, P. B., McGovern, A., Fonzetti, P., Zaydens, H., and Alexopoulos, G. S., “Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia.”, J Alzheimers Dis, vol. 48, no. 2, pp. 453-62, 2015.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., “Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.”, J Alzheimers Dis, 2015.
Q. Zhao, Roberts, R. O., Ding, D., Cha, R., Guo, Q., Meng, H., Luo, J., Machulda, M. M., V Pankratz, S., Wang, B., Christianson, T. J. H., Aakre, J. A., Knopman, D. S., Boeve, B. F., Hong, Z., and Petersen, R. C., “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
G. J. Brewer, “Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
2012
K. Talbot, Wang, H. - Y., Kazi, H., Han, L. - Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E., “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
2011
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H., “The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
M. S. Albert, DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., and Phelps, C. H., “The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 270-9, 2011.
L. Qiang, Fujita, R., Yamashita, T., Angulo, S., Rhinn, H., Rhee, D., Doege, C., Chau, L., Aubry, L., Vanti, W. B., Moreno, H., and Abeliovich, A., “Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons.”, Cell, vol. 146, no. 3, pp. 359-71, 2011.
D. Kapogiannis and Mattson, M. P., “Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.”, Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.

Pages